Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastroesophageal Reflux | 7 | 2022 | 117 | 4.070 |
Why?
|
Laparoscopy | 15 | 2023 | 746 | 3.630 |
Why?
|
Appendicitis | 4 | 2023 | 62 | 3.100 |
Why?
|
Fundoplication | 6 | 2022 | 72 | 2.060 |
Why?
|
Hernia, Umbilical | 4 | 2022 | 17 | 1.950 |
Why?
|
Child | 33 | 2024 | 6913 | 1.730 |
Why?
|
Thoracoscopy | 3 | 2016 | 22 | 1.620 |
Why?
|
Gastroschisis | 5 | 2022 | 13 | 1.560 |
Why?
|
Cranial Sutures | 5 | 2009 | 47 | 1.420 |
Why?
|
Cholecystectomy, Laparoscopic | 3 | 2023 | 50 | 1.370 |
Why?
|
Pandemics | 5 | 2022 | 739 | 1.360 |
Why?
|
Appendectomy | 4 | 2023 | 32 | 1.250 |
Why?
|
Retrospective Studies | 28 | 2023 | 8431 | 0.970 |
Why?
|
Esophageal Atresia | 2 | 2024 | 13 | 0.960 |
Why?
|
Peritoneal Dialysis | 1 | 2023 | 32 | 0.940 |
Why?
|
Treatment Outcome | 19 | 2023 | 7949 | 0.900 |
Why?
|
Humans | 64 | 2024 | 86281 | 0.870 |
Why?
|
Esophagoplasty | 1 | 2021 | 10 | 0.820 |
Why?
|
Gastric Bypass | 1 | 2022 | 110 | 0.810 |
Why?
|
Biliary Dyskinesia | 2 | 2019 | 3 | 0.790 |
Why?
|
Craniosynostoses | 4 | 2009 | 77 | 0.780 |
Why?
|
Dura Mater | 5 | 2009 | 44 | 0.780 |
Why?
|
Magnets | 2 | 2024 | 14 | 0.780 |
Why?
|
Analgesics, Opioid | 3 | 2022 | 411 | 0.750 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2020 | 99 | 0.710 |
Why?
|
Infant | 11 | 2022 | 3036 | 0.690 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 509 | 0.660 |
Why?
|
Infant, Newborn | 11 | 2022 | 2369 | 0.650 |
Why?
|
Anus, Imperforate | 1 | 2018 | 11 | 0.650 |
Why?
|
Surgical Staplers | 1 | 2018 | 11 | 0.650 |
Why?
|
Rectal Fistula | 1 | 2018 | 18 | 0.640 |
Why?
|
Critical Illness | 1 | 2020 | 293 | 0.620 |
Why?
|
Umbilicus | 2 | 2017 | 5 | 0.600 |
Why?
|
Gallbladder Diseases | 1 | 2017 | 22 | 0.590 |
Why?
|
Critical Care | 1 | 2020 | 368 | 0.590 |
Why?
|
Child, Preschool | 12 | 2023 | 3608 | 0.590 |
Why?
|
Funnel Chest | 3 | 2024 | 8 | 0.580 |
Why?
|
Liver Neoplasms | 4 | 2023 | 731 | 0.580 |
Why?
|
Tracheoesophageal Fistula | 1 | 2016 | 11 | 0.560 |
Why?
|
Pediatrics | 1 | 2020 | 344 | 0.550 |
Why?
|
Vascular Malformations | 1 | 2015 | 19 | 0.540 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 38 | 0.530 |
Why?
|
Colorectal Neoplasms | 4 | 2023 | 924 | 0.530 |
Why?
|
Thoracic Duct | 1 | 2015 | 3 | 0.530 |
Why?
|
Bone Regeneration | 4 | 2011 | 52 | 0.530 |
Why?
|
Chylothorax | 1 | 2015 | 7 | 0.530 |
Why?
|
Pleurodesis | 1 | 2015 | 8 | 0.520 |
Why?
|
Adolescent | 14 | 2023 | 8968 | 0.520 |
Why?
|
Physicians | 1 | 2022 | 672 | 0.490 |
Why?
|
Abnormalities, Multiple | 1 | 2015 | 232 | 0.480 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.450 |
Why?
|
Castleman Disease | 1 | 2013 | 13 | 0.450 |
Why?
|
Mediastinal Diseases | 1 | 2013 | 21 | 0.450 |
Why?
|
Mediastinum | 1 | 2013 | 46 | 0.450 |
Why?
|
Anatomic Landmarks | 1 | 2012 | 31 | 0.440 |
Why?
|
Skull | 3 | 2009 | 248 | 0.440 |
Why?
|
Ligation | 3 | 2018 | 51 | 0.430 |
Why?
|
Stents | 2 | 2019 | 375 | 0.420 |
Why?
|
Mesoderm | 2 | 2009 | 107 | 0.400 |
Why?
|
Choledocholithiasis | 2 | 2023 | 12 | 0.390 |
Why?
|
Spherocytosis, Hereditary | 1 | 2010 | 2 | 0.390 |
Why?
|
Catheter Ablation | 2 | 2023 | 233 | 0.390 |
Why?
|
Splenectomy | 1 | 2010 | 82 | 0.380 |
Why?
|
Tissue Engineering | 3 | 2011 | 181 | 0.380 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 5 | 0.360 |
Why?
|
Endoscopy | 4 | 2024 | 331 | 0.350 |
Why?
|
Diaphragmatic Eventration | 1 | 2009 | 1 | 0.350 |
Why?
|
Adult | 7 | 2023 | 25577 | 0.350 |
Why?
|
Hernia, Diaphragmatic | 1 | 2009 | 10 | 0.350 |
Why?
|
Male | 20 | 2023 | 40860 | 0.350 |
Why?
|
Minimally Invasive Surgical Procedures | 8 | 2024 | 234 | 0.350 |
Why?
|
Hernias, Diaphragmatic, Congenital | 1 | 2009 | 14 | 0.350 |
Why?
|
Postoperative Complications | 8 | 2022 | 2183 | 0.340 |
Why?
|
Bone Development | 1 | 2009 | 34 | 0.340 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 380 | 0.340 |
Why?
|
Osteogenesis | 3 | 2009 | 241 | 0.330 |
Why?
|
Xenopus laevis | 1 | 2009 | 137 | 0.330 |
Why?
|
Suture Techniques | 2 | 2013 | 134 | 0.330 |
Why?
|
Aortic Rupture | 1 | 2008 | 55 | 0.320 |
Why?
|
Morphogenesis | 1 | 2009 | 188 | 0.310 |
Why?
|
Female | 18 | 2023 | 44405 | 0.300 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2008 | 112 | 0.300 |
Why?
|
Bone and Bones | 1 | 2008 | 264 | 0.290 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2007 | 72 | 0.290 |
Why?
|
Blood Vessel Prosthesis | 1 | 2008 | 228 | 0.280 |
Why?
|
Drainage | 2 | 2023 | 157 | 0.280 |
Why?
|
Herniorrhaphy | 3 | 2022 | 78 | 0.280 |
Why?
|
Pneumothorax | 2 | 2013 | 51 | 0.280 |
Why?
|
Surgeons | 2 | 2021 | 236 | 0.280 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2008 | 208 | 0.270 |
Why?
|
Robotics | 1 | 2009 | 266 | 0.270 |
Why?
|
Operative Time | 2 | 2017 | 126 | 0.270 |
Why?
|
Hyperparathyroidism | 1 | 2005 | 67 | 0.260 |
Why?
|
Practice Patterns, Physicians' | 2 | 2021 | 578 | 0.260 |
Why?
|
Pain, Postoperative | 3 | 2022 | 240 | 0.250 |
Why?
|
Parathyroidectomy | 1 | 2005 | 78 | 0.250 |
Why?
|
Patient Selection | 1 | 2008 | 685 | 0.250 |
Why?
|
Elective Surgical Procedures | 3 | 2022 | 116 | 0.250 |
Why?
|
Bone Diseases | 3 | 2008 | 54 | 0.240 |
Why?
|
Peritoneum | 1 | 2023 | 57 | 0.240 |
Why?
|
Fluoroscopy | 2 | 2024 | 119 | 0.230 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2022 | 152 | 0.230 |
Why?
|
Obesity | 2 | 2022 | 962 | 0.230 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 110 | 0.230 |
Why?
|
Dilatation | 2 | 2021 | 46 | 0.230 |
Why?
|
Publications | 1 | 2022 | 26 | 0.220 |
Why?
|
Catheterization | 1 | 2023 | 232 | 0.220 |
Why?
|
Radiography | 2 | 2017 | 812 | 0.210 |
Why?
|
Cardiac Surgical Procedures | 1 | 2007 | 461 | 0.210 |
Why?
|
Disease Models, Animal | 5 | 2009 | 2227 | 0.210 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 49 | 0.210 |
Why?
|
Osteoblasts | 4 | 2011 | 94 | 0.210 |
Why?
|
Rectal Neoplasms | 1 | 2023 | 114 | 0.210 |
Why?
|
Efficiency | 1 | 2022 | 40 | 0.210 |
Why?
|
Benchmarking | 1 | 2022 | 78 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 139 | 0.200 |
Why?
|
Parietal Bone | 3 | 2011 | 20 | 0.200 |
Why?
|
Hernia, Inguinal | 1 | 2022 | 66 | 0.200 |
Why?
|
Heller Myotomy | 1 | 2021 | 6 | 0.200 |
Why?
|
Consensus | 1 | 2022 | 333 | 0.200 |
Why?
|
Chest Tubes | 2 | 2015 | 22 | 0.200 |
Why?
|
Education, Medical, Continuing | 1 | 2022 | 107 | 0.190 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2021 | 38 | 0.190 |
Why?
|
Sutureless Surgical Procedures | 1 | 2020 | 6 | 0.190 |
Why?
|
Wound Closure Techniques | 1 | 2020 | 14 | 0.190 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 57 | 0.180 |
Why?
|
Surgery Department, Hospital | 1 | 2020 | 42 | 0.180 |
Why?
|
Abdominal Wall | 1 | 2020 | 30 | 0.180 |
Why?
|
Sutures | 1 | 2020 | 51 | 0.180 |
Why?
|
Esophageal Stenosis | 1 | 2019 | 26 | 0.180 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 161 | 0.180 |
Why?
|
Follow-Up Studies | 2 | 2019 | 3616 | 0.170 |
Why?
|
Time Factors | 4 | 2015 | 5198 | 0.170 |
Why?
|
Length of Stay | 4 | 2023 | 697 | 0.170 |
Why?
|
Radiography, Interventional | 1 | 2019 | 150 | 0.160 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 739 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2019 | 141 | 0.160 |
Why?
|
Histamine H2 Antagonists | 1 | 2017 | 15 | 0.160 |
Why?
|
Diet Therapy | 1 | 2017 | 20 | 0.160 |
Why?
|
Failure to Thrive | 1 | 2017 | 17 | 0.160 |
Why?
|
Animals | 11 | 2011 | 26518 | 0.150 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 31 | 0.150 |
Why?
|
Gangrene | 1 | 2017 | 7 | 0.150 |
Why?
|
Electric Impedance | 1 | 2017 | 104 | 0.150 |
Why?
|
Societies, Medical | 1 | 2021 | 572 | 0.150 |
Why?
|
Rectum | 1 | 2018 | 146 | 0.150 |
Why?
|
Patient Positioning | 1 | 2017 | 63 | 0.150 |
Why?
|
Appendix | 1 | 2017 | 31 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 3 | 2009 | 1214 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 493 | 0.140 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 9 | 0.140 |
Why?
|
Tracheal Neoplasms | 1 | 2016 | 8 | 0.140 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2016 | 17 | 0.140 |
Why?
|
Signal Transduction | 5 | 2009 | 3233 | 0.140 |
Why?
|
Thoracotomy | 1 | 2016 | 58 | 0.140 |
Why?
|
Regression Analysis | 1 | 2017 | 595 | 0.130 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2015 | 15 | 0.130 |
Why?
|
United States | 3 | 2022 | 6637 | 0.130 |
Why?
|
Tissue Adhesives | 1 | 2015 | 23 | 0.130 |
Why?
|
Retreatment | 1 | 2015 | 107 | 0.130 |
Why?
|
Analysis of Variance | 1 | 2017 | 912 | 0.130 |
Why?
|
Postoperative Care | 1 | 2016 | 220 | 0.130 |
Why?
|
Reproducibility of Results | 1 | 2021 | 2699 | 0.120 |
Why?
|
Treatment Failure | 1 | 2015 | 284 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 148 | 0.120 |
Why?
|
Surveys and Questionnaires | 1 | 2022 | 2495 | 0.120 |
Why?
|
Orthopedic Fixation Devices | 1 | 2013 | 5 | 0.120 |
Why?
|
Bezoars | 1 | 2013 | 4 | 0.120 |
Why?
|
Venous Cutdown | 1 | 2013 | 2 | 0.120 |
Why?
|
Microwaves | 2 | 2023 | 34 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2013 | 38 | 0.120 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2013 | 43 | 0.110 |
Why?
|
Rats | 3 | 2009 | 3984 | 0.110 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 126 | 0.110 |
Why?
|
Jugular Veins | 1 | 2013 | 69 | 0.110 |
Why?
|
Quality of Life | 1 | 2021 | 1575 | 0.110 |
Why?
|
Wound Healing | 2 | 2012 | 342 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 877 | 0.110 |
Why?
|
Cicatrix | 1 | 2012 | 63 | 0.110 |
Why?
|
Transforming Growth Factor beta3 | 2 | 2009 | 16 | 0.110 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2009 | 7 | 0.110 |
Why?
|
Transforming Growth Factor beta2 | 2 | 2009 | 15 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 116 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 123 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2009 | 87 | 0.100 |
Why?
|
Duodenostomy | 1 | 2011 | 1 | 0.100 |
Why?
|
Superior Mesenteric Artery Syndrome | 1 | 2011 | 3 | 0.100 |
Why?
|
Hepatectomy | 2 | 2023 | 166 | 0.100 |
Why?
|
Jejunostomy | 1 | 2011 | 14 | 0.100 |
Why?
|
Cohort Studies | 3 | 2022 | 2759 | 0.100 |
Why?
|
Age Factors | 3 | 2010 | 1842 | 0.100 |
Why?
|
Trichotillomania | 1 | 2013 | 88 | 0.100 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 106 | 0.090 |
Why?
|
Organ Size | 1 | 2010 | 363 | 0.090 |
Why?
|
Metamorphosis, Biological | 1 | 2009 | 9 | 0.090 |
Why?
|
Spleen | 1 | 2010 | 430 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 689 | 0.090 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2009 | 17 | 0.090 |
Why?
|
Stem Cells | 2 | 2008 | 350 | 0.090 |
Why?
|
Cartilage | 1 | 2009 | 113 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2008 | 24 | 0.080 |
Why?
|
Growth Substances | 1 | 2008 | 80 | 0.080 |
Why?
|
Larva | 1 | 2009 | 117 | 0.080 |
Why?
|
Aortography | 1 | 2008 | 63 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2009 | 307 | 0.080 |
Why?
|
Cleft Palate | 1 | 2008 | 25 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2011 | 1456 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2011 | 1752 | 0.080 |
Why?
|
Regenerative Medicine | 1 | 2008 | 23 | 0.080 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2008 | 49 | 0.080 |
Why?
|
Congenital Abnormalities | 1 | 2008 | 63 | 0.080 |
Why?
|
Neck | 1 | 2008 | 100 | 0.080 |
Why?
|
Preoperative Care | 1 | 2010 | 390 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 261 | 0.080 |
Why?
|
In Vitro Techniques | 1 | 2009 | 987 | 0.080 |
Why?
|
Gastric Fistula | 1 | 2007 | 5 | 0.080 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 11 | 0.080 |
Why?
|
Stromal Cells | 1 | 2008 | 142 | 0.080 |
Why?
|
Young Adult | 2 | 2017 | 5961 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2008 | 277 | 0.080 |
Why?
|
Regeneration | 1 | 2008 | 143 | 0.080 |
Why?
|
Models, Animal | 1 | 2008 | 261 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2010 | 1015 | 0.070 |
Why?
|
Enteral Nutrition | 1 | 2007 | 102 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2007 | 109 | 0.070 |
Why?
|
Risk Factors | 1 | 2017 | 5397 | 0.070 |
Why?
|
Mice | 6 | 2011 | 11313 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2008 | 240 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 859 | 0.070 |
Why?
|
Intraoperative Complications | 1 | 2007 | 183 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 2594 | 0.070 |
Why?
|
Palliative Care | 1 | 2007 | 256 | 0.070 |
Why?
|
Video Recording | 1 | 2005 | 190 | 0.060 |
Why?
|
Common Bile Duct | 1 | 2023 | 19 | 0.060 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 62 | 0.060 |
Why?
|
Pneumonia | 2 | 2016 | 178 | 0.060 |
Why?
|
Radiography, Thoracic | 1 | 2005 | 320 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 1381 | 0.050 |
Why?
|
Technology | 1 | 2022 | 29 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2011 | 6481 | 0.050 |
Why?
|
Morphine | 1 | 2022 | 130 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2023 | 347 | 0.050 |
Why?
|
Esophagitis, Peptic | 1 | 2021 | 10 | 0.050 |
Why?
|
Esophageal Sphincter, Lower | 1 | 2021 | 32 | 0.050 |
Why?
|
Observational Studies as Topic | 1 | 2021 | 48 | 0.050 |
Why?
|
RNA, Viral | 1 | 2022 | 327 | 0.050 |
Why?
|
Risk Assessment | 1 | 2008 | 2253 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2001 | 51 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2021 | 307 | 0.050 |
Why?
|
Publishing | 1 | 2021 | 90 | 0.050 |
Why?
|
Imidazoles | 1 | 2001 | 163 | 0.050 |
Why?
|
Hospitals | 1 | 2022 | 290 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 222 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 1917 | 0.040 |
Why?
|
Aged | 2 | 2008 | 18353 | 0.040 |
Why?
|
Deglutition Disorders | 1 | 2021 | 115 | 0.040 |
Why?
|
Gallbladder | 1 | 2019 | 30 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2019 | 18 | 0.040 |
Why?
|
Motivation | 1 | 2021 | 287 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 4194 | 0.040 |
Why?
|
Hospitalization | 1 | 2023 | 844 | 0.040 |
Why?
|
Craniotomy | 2 | 2008 | 88 | 0.040 |
Why?
|
Bronchoscopy | 1 | 2016 | 152 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2016 | 195 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 2013 | 25 | 0.030 |
Why?
|
Hemothorax | 1 | 2013 | 15 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2013 | 45 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2013 | 35 | 0.030 |
Why?
|
Syndrome | 1 | 2013 | 446 | 0.030 |
Why?
|
Device Removal | 1 | 2013 | 159 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 183 | 0.030 |
Why?
|
Reoperation | 1 | 2013 | 589 | 0.020 |
Why?
|
Ultrasonography | 1 | 2013 | 695 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 179 | 0.020 |
Why?
|
Genetic Markers | 1 | 2011 | 476 | 0.020 |
Why?
|
Glycoproteins | 1 | 2011 | 234 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 781 | 0.020 |
Why?
|
Thyroglossal Cyst | 1 | 2008 | 3 | 0.020 |
Why?
|
Subcutaneous Tissue | 1 | 2008 | 10 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 302 | 0.020 |
Why?
|
Dermoid Cyst | 1 | 2008 | 15 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 36 | 0.020 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2008 | 10 | 0.020 |
Why?
|
Tartrate-Resistant Acid Phosphatase | 1 | 2008 | 4 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 468 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2008 | 33 | 0.020 |
Why?
|
LIM-Homeodomain Proteins | 1 | 2008 | 21 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2008 | 33 | 0.020 |
Why?
|
Lipocalins | 1 | 2008 | 35 | 0.020 |
Why?
|
Prealbumin | 1 | 2008 | 34 | 0.020 |
Why?
|
Osteoclasts | 1 | 2008 | 33 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 927 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2008 | 26 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors | 1 | 2008 | 5 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 44 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2008 | 31 | 0.020 |
Why?
|
Parathyroid Neoplasms | 1 | 2008 | 55 | 0.020 |
Why?
|
Veins | 1 | 2008 | 94 | 0.020 |
Why?
|
Axilla | 1 | 2008 | 97 | 0.020 |
Why?
|
Trephining | 1 | 2008 | 2 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 78 | 0.020 |
Why?
|
Osteocytes | 1 | 2008 | 9 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 305 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 78 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 159 | 0.020 |
Why?
|
Actins | 1 | 2011 | 448 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2008 | 132 | 0.020 |
Why?
|
Isoenzymes | 1 | 2008 | 271 | 0.020 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2008 | 53 | 0.020 |
Why?
|
Scalp | 1 | 2008 | 72 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2008 | 231 | 0.020 |
Why?
|
Adenoma | 1 | 2008 | 234 | 0.020 |
Why?
|
Aging | 1 | 2011 | 689 | 0.020 |
Why?
|
Mice, Nude | 1 | 2008 | 790 | 0.020 |
Why?
|
Middle Aged | 1 | 2005 | 24957 | 0.020 |
Why?
|
Up-Regulation | 1 | 2008 | 710 | 0.020 |
Why?
|
Cytokines | 1 | 2008 | 775 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2008 | 535 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 1200 | 0.010 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2001 | 7 | 0.010 |
Why?
|
Drug Stability | 1 | 2001 | 48 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 1051 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 64 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2001 | 88 | 0.010 |
Why?
|
Biological Availability | 1 | 2001 | 92 | 0.010 |
Why?
|
Arthritis | 1 | 2001 | 46 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 125 | 0.010 |
Why?
|
Transcription Factors | 1 | 2008 | 1555 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 408 | 0.010 |
Why?
|
Monocytes | 1 | 2001 | 214 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 285 | 0.010 |
Why?
|
Administration, Oral | 1 | 2001 | 683 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 632 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2001 | 683 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 1958 | 0.010 |
Why?
|